Orthopediatrics (KIDS) Research & Development (2016 - 2026)

Orthopediatrics (KIDS) has 11 years of Research & Development data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Research & Development fell 5.1% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was -$21.6 million, a 123.47% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, down 85.84% from the prior year.
• Research & Development for Q1 2026 stood at $2.2 million, up from -$45.2 million in the prior quarter.
• Over the last five years, Research & Development for KIDS reached as high as $56.2 million in Q4 2024 and fell as low as -$45.2 million in Q4 2025.
• Historically, Research & Development has averaged $8.5 million across 5 years, with a median of $2.6 million in 2023.
• Across the five-year window, Research & Development jumped 1714.36% in 2023 and sank 180.5% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.5 million in 2022, then soared by 1714.36% to $44.9 million in 2023, then advanced by 25.25% to $56.2 million in 2024, then sank by 180.5% to -$45.2 million in 2025, then surged by 104.93% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $2.2 million in Q1 2026, -$45.2 million in Q4 2025, and $2.3 million in Q3 2025.